Lion Biotechnologies to Participate in Upcoming Investor and Scientific Conferences
03 sept. 2015 16h01 HE
|
Lion Biotechnologies, Inc.
NEW YORK, Sept. 3, 2015 (GLOBE NEWSWIRE) -- Lion Biotechnologies (Nasdaq:LBIO), a biotechnology company that is developing novel cancer immunotherapies based on tumor-infiltrating lymphocytes (TIL),...
Lion Biotechnologies Announces Strategic Hires
31 août 2015 08h00 HE
|
Lion Biotechnologies, Inc.
NEW YORK, Aug. 31, 2015 (GLOBE NEWSWIRE) -- Lion Biotechnologies, Inc. (Nasdaq:LBIO), a biotechnology company that is developing novel cancer immunotherapies based on tumor-infiltrating lymphocytes...
Lion Biotechnologies Announces Second Quarter 2015 Financial Results
10 août 2015 16h00 HE
|
Lion Biotechnologies, Inc.
NEW YORK, Aug. 10, 2015 (GLOBE NEWSWIRE) -- Lion Biotechnologies, Inc. (Nasdaq:LBIO), a biotechnology company that is developing novel cancer immunotherapies based on tumor-infiltrating lymphocytes...
Lion Biotechnologies to Join Russell Global Index
24 juin 2015 08h00 HE
|
Lion Biotechnologies, Inc.
LOS ANGELES, June 24, 2015 (GLOBE NEWSWIRE) -- Lion Biotechnologies, Inc. (Nasdaq:LBIO), a biotechnology company that is developing novel cancer immunotherapies based on tumor-infiltrating lymphocytes...
Lion Biotechnologies Receives Orphan Drug Designation for LN-144 for the Treatment of Malignant Melanoma
10 juin 2015 12h00 HE
|
Lion Biotechnologies, Inc.
LOS ANGELES, June 10, 2015 (GLOBE NEWSWIRE) -- Lion Biotechnologies, Inc. (Nasdaq:LBIO), a biotechnology company that is developing novel cancer immunotherapies based on tumor-infiltrating lymphocytes...
Lion Biotechnologies Names Molly Henderson Chief Financial Officer
08 juin 2015 08h00 HE
|
Lion Biotechnologies, Inc.
LOS ANGELES, June 8, 2015 (GLOBE NEWSWIRE) -- Lion Biotechnologies, Inc. (Nasdaq:LBIO), a biotechnology company that is developing novel cancer immunotherapies based on tumor-infiltrating lymphocytes...
Lion Biotechnologies to Participate in Upcoming Investor Conferences
19 mai 2015 08h00 HE
|
Lion Biotechnologies, Inc.
LOS ANGELES, May 19, 2015 (GLOBE NEWSWIRE) -- Lion Biotechnologies, Inc. (Nasdaq:LBIO) today announced that president and CEO Elma Hawkins, PhD, will participate in the following upcoming investor...
Lion Biotechnologies Announces Pricing of Secondary Offering of Shares by Selling Stockholders
01 mai 2015 08h45 HE
|
Lion Biotechnologies, Inc.
LOS ANGELES, May 1, 2015 (GLOBE NEWSWIRE) -- Lion Biotechnologies, Inc. (Nasdaq:LBIO), a biotechnology company that is developing novel cancer immunotherapies based on tumor infiltrating lymphocytes,...
Lion Biotechnologies Announces Publication of Data From Clinical Study of Metastatic Cervical Cancer Patients Treated With HPV-TIL
08 avr. 2015 08h26 HE
|
Lion Biotechnologies, Inc.
LOS ANGELES, April 8, 2015 (GLOBE NEWSWIRE) -- Lion Biotechnologies, Inc. (Nasdaq:LBIO), a biotechnology company that is developing novel cancer immunotherapies based on tumor-infiltrating lymphocytes...
Lion Biotechnologies Announces Positive Data From a TIL-Ipilimumab Combination Study in Melanoma
30 mars 2015 06h00 HE
|
Lion Biotechnologies, Inc.
LOS ANGELES, March 30, 2015 (GLOBE NEWSWIRE) -- Lion Biotechnologies, Inc. (Nasdaq:LBIO), a biotechnology company that is developing novel cancer immunotherapies based on tumor infiltrating...